Company Registration No. 07603756 (England and Wales)
Precision Hydration Limited
Unaudited financial statements
for the year ended 31 December 2025
Pages for filing with the registrar
Precision Hydration Limited
Contents
Page
Statement of financial position
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 12
Precision Hydration Limited
Statement of financial position
As at 31 December 2025
1
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
46,867
37,216
Tangible assets
5
298,186
316,598
Investments
6
91
91
345,144
353,905
Current assets
Stocks
7
4,009,118
1,381,554
Debtors
8
1,296,086
921,854
Cash at bank and in hand
683,804
298,308
5,989,008
2,601,716
Creditors: amounts falling due within one year
9
(3,304,941)
(1,423,174)
Net current assets
2,684,067
1,178,542
Total assets less current liabilities
3,029,211
1,532,447
Creditors: amounts falling due after more than one year
10
(31,727)
Provisions for liabilities
(28,998)
(39,772)
Net assets
2,968,486
1,492,675
Capital and reserves
Called up share capital
12
9,222
9,222
Share premium account
97,500
97,500
Capital redemption reserve
778
778
Profit and loss reserves
2,860,986
1,385,175
Total equity
2,968,486
1,492,675
Precision Hydration Limited
Statement of financial position (continued)
As at 31 December 2025
2
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 5 August 2026 and are signed on its behalf by:
J C Tye
Director
Company Registration No. 07603756
Precision Hydration Limited
Statement of changes in equity
For the year ended 31 December 2025
3
Share capital
Share premium account
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2024
10,000
97,500
1,294,896
1,402,396
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
-
813,675
813,675
Dividends
-
-
-
(362,378)
(362,378)
Own shares acquired
-
-
-
(361,018)
(361,018)
Redemption of shares
12
(778)
-
(778)
Other movements
-
-
778
-
778
Balance at 31 December 2024
9,222
97,500
778
1,385,175
1,492,675
Year ended 31 December 2025:
Profit and total comprehensive income
-
-
-
1,587,811
1,587,811
Dividends
-
-
-
(112,000)
(112,000)
Balance at 31 December 2025
9,222
97,500
778
2,860,986
2,968,486
Precision Hydration Limited
Notes to the financial statements
For the year ended 31 December 2025
4
1
Accounting policies
Company information
Precision Hydration Limited is a private company limited by shares incorporated in England and Wales. The registered office is Hinton Old Sawmill, Hinton, Christchurch, England, BH23 7DX.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Revenue is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Revenue from the sale of goods is recognised when all the following conditions are satisfied:
the Company has transferred to the buyer the significant risks and rewards of ownership of the goods;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the economic benefits associated with the transaction will flow to the Company;
and
Specifically, revenue from the sale of goods is recognised when goods are dispatched and legal title is passed.
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies (continued)
5
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents & licences
10% Straight line
Development costs
20% Straight line
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold land and buildings
20% Straight line
Plant and equipment
25% Straight line
Fixtures and fittings
25% Straight line
Motor vehicles
25% Straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.7
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
1.8
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies (continued)
6
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.9
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to net realisable value.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses.
1.10
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.11
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies (continued)
7
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.12
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies (continued)
8
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.16
Share-based payments
The company operates an equity-settled share-based payment arrangement. The fair value of employee services received in exchange for the grant of share options is recognised as an expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted at the grant date. The expense is recognised over the period during which employees become unconditionally entitled to the awards. At each reporting date, the company revises its estimate of the number of options expected to vest and recognises the impact of any revision in profit or loss, with a corresponding adjustment to equity.
Options that lapse because employees cease employment before satisfying the vesting conditions are treated as forfeitures and are excluded from the number of awards expected to vest.
1.17
Leases
As lessee
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
1.18
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
9
2
Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
34
24
4
Intangible fixed assets
Other
£
Cost
At 1 January 2025
80,789
Additions
19,712
At 31 December 2025
100,501
Amortisation and impairment
At 1 January 2025
43,573
Amortisation charged for the year
10,061
At 31 December 2025
53,634
Carrying amount
At 31 December 2025
46,867
At 31 December 2024
37,216
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
10
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025
233,488
247,164
480,652
Additions
104,151
104,151
At 31 December 2025
233,488
351,315
584,803
Depreciation and impairment
At 1 January 2025
47,727
116,327
164,054
Depreciation charged in the year
46,698
75,865
122,563
At 31 December 2025
94,425
192,192
286,617
Carrying amount
At 31 December 2025
139,063
159,123
298,186
At 31 December 2024
185,761
130,837
316,598
6
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
91
91
7
Stocks
2025
2024
£
£
Stocks
4,009,118
1,381,554
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
52,925
39,186
Amounts owed by group undertakings
375,390
462,015
Other debtors
867,771
420,653
1,296,086
921,854
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
11
9
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
60,590
108,788
Trade creditors
420,130
586,022
Amounts owed to group undertakings
1,809,973
536,510
Corporation tax
130,955
65,640
Other taxation and social security
709,970
42,799
Other creditors
173,323
83,415
3,304,941
1,423,174
10
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
31,727
11
Share-based payment transactions
The Company operates an Enterprise Management Incentive share option scheme. During the year, options were granted over O Ordinary Shares. The options are exercisable only on the occurrence of an exit event, including a sale of substantially all of the Company's business or a sale of a controlling interest in the Company's share capital. The primary vesting condition is continued employment until the exit event, with options generally lapsing when an employee ceases employment before vesting.
The O Ordinary Shares are non-voting and do not carry rights to receive dividends.
Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
£
£
Outstanding at 1 January 2025
Granted
10,000
44.75
Forfeited
44.75
Outstanding at 31 December 2025
9,927
Exercisable at 31 December 2025
The options outstanding at 31 December 2025 had an exercise price of £44.75 and a remaining contractual life of 9.5 years.
Precision Hydration Limited
Notes to the financial statements (continued)
For the year ended 31 December 2025
12
12
Called up share capital
The company has a total of 92,221 shares. The share capital is made up of 92,219 ordinary A £0.10 shares, 1 ordinary B £0.10 share and 1 ordinary C £0.10 share. All shares rank pari passu.
13
Operating lease commitments
2025
2024
£
£
Total commitments under non-cancellable operating leases
202,500
236,250
14
Related party transactions
At the period end, £391,641 (2024: £176,059) is owed to Precision Hydration Limited from companies under common control.
Interest has not been charged on either of these related party debts.
15
Directors' transactions
Dividends totalling £112,000 (2024 : £362,378) were paid in the year in respect of shares held by the company's directors.
Loans
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
A Blow
-
-
90,000
90,000
J Tye
-
-
90,000
90,000
-
180,000
180,000
2025-12-312025-01-01falsefalsefalse05 August 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr A V BlowJ C Tye076037562025-01-012025-12-31076037562025-12-31076037562024-12-3107603756core:IntangibleAssetsOtherThanGoodwill2025-12-3107603756core:IntangibleAssetsOtherThanGoodwill2024-12-3107603756core:LandBuildings2025-12-3107603756core:OtherPropertyPlantEquipment2025-12-3107603756core:LandBuildings2024-12-3107603756core:OtherPropertyPlantEquipment2024-12-3107603756core:CurrentInventories2025-12-3107603756core:CurrentInventories2024-12-3107603756core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3107603756core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107603756core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3107603756core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3107603756core:CurrentFinancialInstruments2025-12-3107603756core:CurrentFinancialInstruments2024-12-3107603756core:ShareCapital2025-12-3107603756core:ShareCapital2024-12-3107603756core:SharePremium2025-12-3107603756core:SharePremium2024-12-3107603756core:CapitalRedemptionReserve2025-12-3107603756core:CapitalRedemptionReserve2024-12-3107603756core:RetainedEarningsAccumulatedLosses2025-12-3107603756core:RetainedEarningsAccumulatedLosses2024-12-3107603756core:ShareCapital2023-12-3107603756core:SharePremium2023-12-3107603756core:CapitalRedemptionReserve2023-12-3107603756core:RetainedEarningsAccumulatedLosses2023-12-3107603756bus:Director22025-01-012025-12-3107603756core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31076037562024-01-012024-12-3107603756core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3107603756core:ShareCapital2024-01-012024-12-3107603756core:SharePremium2024-01-012024-12-3107603756core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3107603756core:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3107603756core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-012025-12-3107603756core:LandBuildingscore:LongLeaseholdAssets2025-01-012025-12-3107603756core:PlantMachinery2025-01-012025-12-3107603756core:FurnitureFittings2025-01-012025-12-3107603756core:MotorVehicles2025-01-012025-12-3107603756core:IntangibleAssetsOtherThanGoodwill2024-12-3107603756core:LandBuildings2024-12-3107603756core:OtherPropertyPlantEquipment2024-12-31076037562024-12-3107603756core:LandBuildings2025-01-012025-12-3107603756core:OtherPropertyPlantEquipment2025-01-012025-12-3107603756core:Non-currentFinancialInstruments2025-12-3107603756core:Non-currentFinancialInstruments2024-12-31076037562023-12-3107603756bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107603756bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107603756bus:FRS1022025-01-012025-12-3107603756bus:AuditExemptWithAccountantsReport2025-01-012025-12-3107603756bus:Director12025-01-012025-12-3107603756bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP